1990
DOI: 10.1001/jama.1990.03440170063037
|View full text |Cite
|
Sign up to set email alerts
|

Biopsy of Occult Breast Lesions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
6
0

Year Published

1990
1990
2017
2017

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 89 publications
(6 citation statements)
references
References 16 publications
0
6
0
Order By: Relevance
“…In practice, the decision on the work-up of BI-RADS 3 lesions depends on the possibilities for biopsy procedures, the wishes of the patient and the preference of the radiologist. Most patients who are referred for a biopsy have benign disease because of the low predictive value of both physical examination and mammography [ 5 , 6 ] . The value of breast MRI in BI-RADS 3 lesions is not yet clear [ 4 ] .…”
Section: Introductionmentioning
confidence: 99%
“…In practice, the decision on the work-up of BI-RADS 3 lesions depends on the possibilities for biopsy procedures, the wishes of the patient and the preference of the radiologist. Most patients who are referred for a biopsy have benign disease because of the low predictive value of both physical examination and mammography [ 5 , 6 ] . The value of breast MRI in BI-RADS 3 lesions is not yet clear [ 4 ] .…”
Section: Introductionmentioning
confidence: 99%
“…Biopsy was the best way to confirm whether a tumor would be benign or malignant, however, it was invasive, carried the risk of infection, and expensive, and only 10% -31% of biopsied tumors were malignant (4,5). To avoid unnecessary biopsy, assuage anxiety, and increased diagnostic confidence, computer-aided diagnosis (CAD) systems have been developed.…”
Section: Introductionmentioning
confidence: 99%
“…Based on imaging characteristics, microcalcifications often cannot be classified as benign or malignant; in these cases, pathological examination by biopsy is recommended [3456]. …”
Section: Introductionmentioning
confidence: 99%